519 related articles for article (PubMed ID: 7520127)
21. The oxazolidinedione CP-92,768-2 partially protects insulin receptor substrate-1 from dexamethasone down-regulation in 3T3-L1 adipocytes.
Turnbow MA; Smith LK; Garner CW
Endocrinology; 1995 Apr; 136(4):1450-8. PubMed ID: 7895655
[TBL] [Abstract][Full Text] [Related]
22. Dexamethasone down-regulation of insulin receptor substrate-1 in 3T3-L1 adipocytes.
Turnbow MA; Keller SR; Rice KM; Garner CW
J Biol Chem; 1994 Jan; 269(4):2516-20. PubMed ID: 8300578
[TBL] [Abstract][Full Text] [Related]
23. Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation. Role of specific intracellular signaling pathways.
Giorgino F; Smith RJ
J Clin Invest; 1995 Sep; 96(3):1473-83. PubMed ID: 7544807
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes.
Takano A; Haruta T; Iwata M; Usui I; Uno T; Kawahara J; Ueno E; Sasaoka T; Kobayashi M
Diabetes; 2001 Aug; 50(8):1891-900. PubMed ID: 11473053
[TBL] [Abstract][Full Text] [Related]
25. Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus.
Folli F; Saad MJ; Backer JM; Kahn CR
J Clin Invest; 1993 Oct; 92(4):1787-94. PubMed ID: 7691886
[TBL] [Abstract][Full Text] [Related]
26. Effect of phosphotyrosyl-IRS-1 level and insulin receptor tyrosine kinase activity on insulin-stimulated phosphatidylinositol 3, MAP, and S6 kinase activities.
Wilden PA; Broadway DE
J Cell Physiol; 1995 Apr; 163(1):9-18. PubMed ID: 7896903
[TBL] [Abstract][Full Text] [Related]
27. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612.
De Fea K; Roth RA
Biochemistry; 1997 Oct; 36(42):12939-47. PubMed ID: 9335553
[TBL] [Abstract][Full Text] [Related]
28. Proteasome inhibitors regulate tyrosine phosphorylation of IRS-1 and insulin signaling in adipocytes.
Rondinone CM; Kramer D
Biochem Biophys Res Commun; 2002 Sep; 296(5):1257-63. PubMed ID: 12207909
[TBL] [Abstract][Full Text] [Related]
29. Insulin signaling in insulin receptor substrate (IRS)-1-deficient brown adipocytes: requirement of IRS-1 for lipid synthesis.
Valverde AM; Kahn CR; Benito M
Diabetes; 1999 Nov; 48(11):2122-31. PubMed ID: 10535444
[TBL] [Abstract][Full Text] [Related]
30. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies.
Almind K; Inoue G; Pedersen O; Kahn CR
J Clin Invest; 1996 Jun; 97(11):2569-75. PubMed ID: 8647950
[TBL] [Abstract][Full Text] [Related]
31. The protein-tyrosine kinase fer associates with signaling complexes containing insulin receptor substrate-1 and phosphatidylinositol 3-kinase.
Iwanishi M; Czech MP; Cherniack AD
J Biol Chem; 2000 Dec; 275(50):38995-9000. PubMed ID: 11006284
[TBL] [Abstract][Full Text] [Related]
32. Adenovirus-mediated overexpression of IRS-1 interacting domains abolishes insulin-stimulated mitogenesis without affecting glucose transport in 3T3-L1 adipocytes.
Sharma PM; Egawa K; Gustafson TA; Martin JL; Olefsky JM
Mol Cell Biol; 1997 Dec; 17(12):7386-97. PubMed ID: 9372969
[TBL] [Abstract][Full Text] [Related]
33. Defective Akt activation is associated with glucose- but not glucosamine-induced insulin resistance.
Nelson BA; Robinson KA; Buse MG
Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E497-506. PubMed ID: 11832350
[TBL] [Abstract][Full Text] [Related]
34. Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling.
Tanti JF; Grémeaux T; van Obberghen E; Le Marchand-Brustel Y
J Biol Chem; 1994 Feb; 269(8):6051-7. PubMed ID: 8119950
[TBL] [Abstract][Full Text] [Related]
35. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1.
Haruta T; Uno T; Kawahara J; Takano A; Egawa K; Sharma PM; Olefsky JM; Kobayashi M
Mol Endocrinol; 2000 Jun; 14(6):783-94. PubMed ID: 10847581
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of protein-tyrosine phosphatase-1B in adipocytes inhibits insulin-stimulated phosphoinositide 3-kinase activity without altering glucose transport or Akt/Protein kinase B activation.
Venable CL; Frevert EU; Kim YB; Fischer BM; Kamatkar S; Neel BG; Kahn BB
J Biol Chem; 2000 Jun; 275(24):18318-26. PubMed ID: 10751417
[TBL] [Abstract][Full Text] [Related]
37. Developmental expression of insulin receptor substrate-2 during dimethylsulfoxide-induced differentiation of human HL-60 cells.
Schacher DH; VanHoy RW; Liu Q; Arkins S; Dantzer R; Freund GG; Kelley KW
J Immunol; 2000 Jan; 164(1):113-20. PubMed ID: 10605001
[TBL] [Abstract][Full Text] [Related]
38. G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Galphaq/11 and insulin receptor substrate-1 pathways in 3T3-L1 adipocytes.
Usui I; Imamura T; Babendure JL; Satoh H; Lu JC; Hupfeld CJ; Olefsky JM
Mol Endocrinol; 2005 Nov; 19(11):2760-8. PubMed ID: 15994203
[TBL] [Abstract][Full Text] [Related]
39. [The expression of the insulin receptor substrate-1 (IRS-1) and analysis of its mechanism].
Shichiri M; Araki E
Nihon Naibunpi Gakkai Zasshi; 1995 Jan; 71(1):21-6. PubMed ID: 7895862
[TBL] [Abstract][Full Text] [Related]
40. Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of Akt-mammalian target of rapamycin/p70 S6 kinase (S6K1) pathway and serine phosphorylation of insulin receptor substrate-1: effect of reduced expression of p85alpha subunit of phosphatidylinositol 3-kinase and S6K1 kinase.
Adochio R; Leitner JW; Hedlund R; Draznin B
Endocrinology; 2009 Mar; 150(3):1165-73. PubMed ID: 18948408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
